Prevention of restenosis after coronary angioplasty: towards a molecular approach?-Reference-Cited by-同舟云学术

Prevention of restenosis after coronary angioplasty: towards a molecular approach?

Published:1995-01-02 Issue:1 Volume:9 Page:8-16
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:

Author:

Feldman LJ,Riessen R.,Steg PG

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1472-8206.1995.tb00259.x/fullpdf

Reference67 articles.

1. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery;Adelman;N Engl J Med,1993

2. Pathological effects of balloon Xe-Hg flash lamp irradiation as photodynamic therapy for the prevention of restenosis;Asahara;J Am Coll Cardiol,1983

3. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty;Bairati;Circulation,1992

4. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides;Bennett;J Clin Invest,1994

5. Expression of heterologous sequences in adenoviral vectors;Berkner;Curr Top Microbiol Immunol,1992

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of CR1 transcript in systemic lupus erythematosus (SLE) by IFN-γ and immune complex;Molecular Immunology;2007-03

2. Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?;Expert Review of Medical Devices;2006-03

3. Anticoagulant and Antiplatelet Agents: Their Clinical and Device Application(s) Together with Usages to Engineer Surfaces;Biomacromolecules;2004-02-24

4. Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells;Life Sciences;2004-01

5. Pharmacological treatment for prevention of restenosis;Expert Opinion on Emerging Drugs;2001-10